IDEXX Laboratories, Inc. IDXX
519.26
5.87
1.14%
as of 25 Sep
- Market cap
- $40.2B
- P/E
- 36.2×
Follow IDXX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
IDEXX Laboratories, Inc. (IDXX) P/S ratio
As of 25 September 2026, IDEXX Laboratories, Inc. (IDXX) trades at a P/S ratio of 9.0×. Over the past ten years it has ranged from 3.7× (January 2016) to 19.8× (August 2021); the current reading is higher than 39% of that period. That is above the Diagnostics & Research industry median of 4.9× and above the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 12.6× | 44.52% |
| FY2024 | 8.7× | (29.61%) |
| FY2023 | 12.4× | 23.25% |
| FY2022 | 10.1× | (42.21%) |
| FY2021 | 17.4× | 10.70% |
| FY2020 | 15.8× | 68.70% |
| FY2019 | 9.3× | 27.97% |
| FY2018 | 7.3× | 3.79% |
| FY2017 | 7.0× | 18.35% |
| FY2016 | 5.9× | 41.00% |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 9.1× | (9.31%) |
| Mar 2026 | 10.1× | (20.38%) |
| Dec 2025 | 12.6× | 2.96% |
| Sep 2025 | 12.3× | 14.96% |
| 42 more quarters | Free account |
Against its own ten years
Low 3.7×
High 19.8×
Ten-year median
9.8×
Current reading's percentile
39
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| DGX Quest Diagnostics Incorporated compare | 2.3× |
| IQV IQVIA Holdings Inc. compare | 2.6× |
| A Agilent Technologies, Inc. compare | 6.6× |
| MTD Mettler-Toledo International, Inc. compare | 7.4× |
| IDXX IDEXX Laboratories, Inc. | 9.0× |
| ILMN Illumina, Inc. compare | 9.2× |
| WAT Waters Corporation compare | 9.2× |
| GH Guardant Health, Inc. compare | 19.9× |
| NTRA Natera, Inc. compare | 21.8× |
| Diagnostics & Research industry median | 4.9× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on IDXX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement